Actionability classification of variants of unknown significance correlates with functional effect.

Johnson, Amber; Ng, Patrick Kwok-Shing; Kahle, Michael; Castillo, Julia; Amador, Bianca; Wang, Yujia; Zeng, Jia; Holla, Vijaykumar; Vu, Thuy; Su, Fei; Kim, Sun-Hee; Conway, Tara; Jiang, Xianli; Chen, Ken; Shaw, Kenna R Mills; Yap, Timothy A; Rodon, Jordi; Mills, Gordon B; Meric-Bernstam, Funda

Johnson, Amber; Ng, Patrick Kwok-Shing; Kahle, Michael; Castillo, Julia; Amador, Bianca; Wang, Yujia; Zeng, Jia; Holla, Vijaykumar; Vu, Thuy; Su, Fei; Kim, Sun-Hee; Conway, Tara; Jiang, Xianli; Chen, Ken; Shaw, Kenna R Mills; Yap, Timothy A; Rodon, Jordi; Mills, Gordon B; Meric-Bernstam, Funda.

Afiliação

Johnson A; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ng PK; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kahle M; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Castillo J; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Amador B; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wang Y; Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zeng J; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Holla V; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Vu T; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Su F; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kim SH; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Conway T; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jiang X; Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chen K; Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shaw KRM; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yap TA; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rodon J; Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mills GB; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Meric-Bernstam F; Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

NPJ Precis Oncol ; 7(1): 67, 2023 Jul 15.

Article em En | MEDLINE | ID: mdl-37454202

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google